MENU
+Compare
PILL
ETF ticker: NYSE ARCA
AS OF
Apr 2, 04:59 PM (EDT)
Price
$6.37
Change
+$0.03 (+0.47%)
Net Assets
10.8M

PILL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index... Show more

Category: #Trading
PILL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for PILL with price predictions
Apr 01, 2025

PILL's RSI Oscillator recovers from oversold territory

The RSI Oscillator for PILL moved out of oversold territory on March 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In of the 30 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PILL advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

PILL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PILL as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PILL turned negative on March 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

PILL moved below its 50-day moving average on March 03, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PILL crossed bearishly below the 50-day moving average on March 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PILL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PILL entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF is 51.26B. The market cap for tickers in the group ranges from 30.34M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is MRNS at 30.34M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was 47%. For the same ETF, the average monthly price growth was 42%, and the average quarterly price growth was 85%. CORT experienced the highest price growth at 58%, while SAVA experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was 13%. For the same stocks of the ETF, the average monthly volume growth was -3% and the average quarterly volume growth was 110%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 73
Price Growth Rating: 56
SMR Rating: 75
Profit Risk Rating: 69
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
PILL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/